Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
Thumbnail

Obama admin to seek $6.2B in emergency Ebola funding

The Obama administration is set to ask Congress for about $6.2 billion in emergency funding to stem the spread of Ebola, reports Bloomberg.

Feds, Mass. reach five year, $41.4B healthcare deal

Massachusetts and the federal government have reached a five-year, $41.4 billion healthcare accord, which will follow a three-year $26.75 billion waiver agreement that expired June 30, reports WBUR.

How the Supreme Court decision impacted HIX enrollment

A data analysis by The New York Times reveals that more than 3 million people would have received insurance across 24 states if the Supreme Court had ruled differently in 2012.

Judge rejects quarantine for Maine nurse

 A judge has ruled that Kaci Hickox, a Maine nurse who had treated Ebola patients, does not have to be fully quarantined, reports The Washington Post.  

Feds open HIX portal for small businesses

The federal government has opened a new health insurance portal for small businesses in five states—Delaware, Illinois, Missouri, New Jersey and Ohio—after a one-year delay for small-employer health plans, according to The Wall Street Journal.

LA Times Editorial Board weighs in on ACA

There is no easy way to put a lid on healthcare costs, according to a piece by the Los Angeles Times editorial board.

CDC issues new Ebola guidelines

The Centers for Disease Control and Prevention has issued new guidelines pertaining to health workers entering the U.S. from Ebola-affected countries, according to Time.

Thumbnail

Health economist shares his struggles with selecting a health plan

Think figuring out a health plan is hard? In a New York Times editorial, health economist Austin Frakt admitted: “I cannot rationally select a health plan.”

Displaying 2713 - 2720 of 2769

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup